Indeed, in pre-clinical melanoma models, the presence in melanoma cells and/or stromal cells of the IL-15/IL-15Rα complex (either in membrane-bound or soluble form) (37, 38), or treatment with IL-15clpx, may lead to the inhibition of tumor progression and reduction of the lung and liver metastases (39). This evidence concerns the gene IL15 and melanoma.